Stopping GLP-1 drugs linked to twice the risk of heart attack

A study of more than 80,000 people with type 2 diabetes in Italy found that discontinuing GLP-1 drugs was associated with twice the risk of heart attack, stroke or death compared with continued treatment. The association was stronger among people with obesity, but researchers cautioned that the findings do not establish causation.